Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Vyome Holdings, Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +3 vs. Q1 2026
- Shares held
- 138.0K
- +46.0K (+50.0%) vs. Q1 2026
- Total value
- $296.5K
- +$98.2K (+49.5%) vs. Q1 2026
- New holders
- 4
- 2 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $296.5K |
| Q1 2026 | 9 | $198.3K |
| Q4 2025 | 8 | $322.3K |
| Q3 2025 | 5 | $125.4K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Vyome Holdings, Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 25,972 | $55.8K | 0.00% | +25,972 | New |
| Geode Capital Management, LLC | 25,793 | $55.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 20,318 | $43.0K | 0.00% | +20,318 | New |
| Colony Group, LLC | 14,640 | $31.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 12,195 | $26.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,908 | $25.6K | 0.00% | −10,767−47.5% | Reduced |
| Susquehanna International Group, LLP | 10,058 | $21.6K | 0.00% | +10,058 | New |
| Vanguard Capital Management LLC | 9,463 | $20.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,856 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,808 | $3.89K | 0.00% | +417+30.0% | Added |
| Barclays PLC | 26 | $56 | 0.00% | +26 | New |
| Caitong International Asset Management Co., Ltd | 3 | $6 | 0.00% | +1+50.0% | Added |
| Citigroup Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |